Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.80 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.80 |
| ▸ | MEN1 | O00255 | 1/20 | 0.73 |
| ▸ | GLA | P06280 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.73 |
| ▸ | TSHR | P16473 | 2/20 | 0.69 |
| ▸ | KDM1A | O60341 | 5/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | SAT1 | P21673 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
| ▸ | ADH1B | P00325 | 1/20 | 0.41 |
| ▸ | ADH1C | P00326 | 1/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
| ▸ | ADH4 | P08319 | 1/20 | 0.41 |
| ▸ | ADH7 | P40394 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL331540 | 1.00 | CYP2C19 (0.80) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL13893419 | 1.00 | CYP2C19 (0.80) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL19620508 | 1.00 | CYP2C19 (0.80) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL332342 | 1.00 | CYP2C19 (0.80) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL331498 | 1.00 | CYP2C19 (0.80) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL7097560 | 0.96 | CYP2C19 (0.87) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL7091884 | 0.96 | CYP2C19 (0.87) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL7096788 | 0.96 | CYP2C19 (0.87) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL7513770 | 0.96 | CYP2C19 (0.87) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL7092406 | 0.96 | CYP2C19 (0.87) | CYP2C19CYP1A2MEN1GLAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090111737-A1 | Novel antibacterial agents | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2009-04-30 | — | — | US | disclosed |
| US-20030166054-A1 | Enhanced in vitro protein synthesis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-09-04 | — | — | US | disclosed |
| US-4212964-A | FOR ADHESIVES | PHILLIPS PETROLEUM COMPANY (US) | 1980-07-15 | — | — | US | disclosed |
| US-4212965-A | MOLDING MATERIAL, HOT MELT ADHESIVES, COATINGS | PHILLIPS PETROLEUM COMPANY (US) | 1980-07-15 | — | — | US | disclosed |
| US-4207411-A | TENSILE STRENGTH, DUCTILITY, AND TOUGHNESS | PHILLIPS PETROLEUM COMPANY (US) | 1980-06-10 | — | — | US | disclosed |
| US-4062909-A | FIRE RETARDANTS | MONSANTO COMPANY (US) | 1977-12-13 | — | — | US | disclosed |
| US-4051087-A | LAMINATES, ADHESIVES | PHILLIPS PETROLEUM COMPANY (US) | 1977-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111737-A1 | Novel antibacterial agents | ENGASE, PGLS, PEPD | CYP2C19 2854/4885CYP1A2 2966/4885MEN1 3984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.